Latest News about mRNA
Recent news which mentions mRNA
Moderna Stock: A Deep Dive Into Analyst Perspectives (10 Ratings)
January 15, 2025
Tickers
MRNA
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 13, 2025
From Benzinga
Stocks Edge Down Ahead Of Key Inflation Reports, Crude Hits 5-Month High, Bitcoin Sinks: What's Driving Markets Monday?
January 13, 2025
From Benzinga
Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge
January 13, 2025
From Benzinga
Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge
January 13, 2025
From Benzinga
Moderna Stock Plummets After $1 Billion Cut to 2025 Sales Forecast
January 13, 2025
From Wall Street Pit
Moderna Expects Lower Annual Sales, Expands Cost-Cutting Initiatives
January 13, 2025
From Benzinga
"Motley Fool Money" 2025 Stock Market Preview
January 08, 2025
From Motley Fool
From Benzinga
From Motley Fool
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
January 07, 2025
From Benzinga
Stocks Sink As Bond Yields Soar, Nvidia Eyes Worst Day In 4 Months, Bitcoin Tumbles To $97,000: What's Driving Markets Tuesday?
January 07, 2025
From Benzinga
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
January 07, 2025
From Benzinga
From Benzinga
Spotlight on Moderna: Analyzing the Surge in Options Activity
January 07, 2025
Tickers
MRNA
From Benzinga
From Benzinga
Investors Look Back at 2024
January 06, 2025
From Motley Fool
Why Moderna (MRNA) Stock Is Trading Higher
January 06, 2025
From Benzinga
3 Growth Stocks That Could Skyrocket in 2025 and Beyond
January 05, 2025
From Motley Fool
Meet the Newest Stock in the Nasdaq-100. It's Soared 110,600% Since Its IPO and It's Still a Buy Heading Into 2025, According to Wall Street.
December 27, 2024
From Motley Fool
US Stocks To Open Higher As Wall Street Expects 'Santa Rally' In Shortened Trading Week: MicroStrategy, Palantir, Qualcomm Among Stocks In Focus
December 23, 2024
From Benzinga
3 Stocks That Could Turn $1,000 into $5,000 by 2030
December 20, 2024
From Motley Fool
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
December 18, 2024
From Motley Fool
Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
December 17, 2024
From Benzinga
Super Micro Drops Below 50-Day Average, Faces Nasdaq 100 Removal Just Months After Entry
December 16, 2024
From Benzinga
What's Going On Moderna Stock On Monday?
December 16, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.